NALIRIFOX Drug Combination Breaks Through in Metastatic Pancreatic Cancer

NALIRIFOX Drug Combination Breaks Through in Metastatic Pancreatic Cancer

Pancreatic cancer is the eighth tumor with the highest incidence in Spain, but it is one of the tumors with the worst prognosis five years after diagnosis. The lack of improvement in survival and the increase in the incidence of this tumor have made the predictions situate … Pancreatic cancer is the eighth tumor with … Read more